Jill Alldredge, MD
Assistant Professor, OB-GYN-Gynecologic Oncology

Download CV
Medical School:
  • MD, University of New Mexico School of Medicine (2011)
Undergraduate School:
  • BA, Colorado College (CO) (2006)
  • University of New Mexico Program, Chief Resident, Obstetrics and Gynecology (2015)
  • University of California (Irvine) Program, Gynecologic Oncology (2019)
Languages: English
Department: OB-GYN-Gynecologic Oncology

Research Interests

I am committed to the discovery of new therapeutic options in both ovarian and uterine cancer, as well as rare tumors, such as uterine sarcomas. I am passionate about quality improvement initiatives to improve patient outcomes during and after surgery. I aim to expand my research in increasing patient education through technology.


  • Hall KC, Post MD, Alldredge J, Aisner DL, Berning A. Molecular Evidence for Epithelial Origin of Mixed Ovarian Epithelial-Germ Cell Neoplasms: Report of 2 Cases and Review of Literature. Int J Gynecol Pathol. 2022 Oct 28. [Epub ahead of print] PubMed PMID: 36305517
  • Hill BL, Goon K, Fresia J, Sheeder J, Wolsky RJ, Alldredge J. Does Lymph Node Dissection Impact Adjuvant Treatment or Survival Outcomes in High-Risk Endometrial Cancers?. Cureus. 2022 May;14(5):e24710. PubMed PMID: 35663703
  • D'Amora P, Silva IDCG, Tewari KS, Bristow RE, Cappuccini F, Evans SS, Salzgeber MB, Addis-Bernard PJ, Palma AM, Marchioni DML, Carioca AAF, Penner KR, Alldredge J, Longoria T, Nagourney RA. Platinum resistance in gynecologic malignancies: Response, disease free and overall survival are predicted by biochemical signature: A metabolomic analysis. Gynecol Oncol. 2021 Oct;163(1):162-170. PubMed PMID: 34446269
  • Hill B, Alldredge J. An overview of chemotherapy-induced peripheral neuropathy resulting from regimen used in gynecologic malignancies. Indian J Gynecol Oncol. 2021. 19:62
  • Hill B, Alldredge J. Does lymph node dissection impact adjuvant treatment or survival outcomes in high-risk endometrial cancers? Poster presentation and abstract to be published at Western Association of Gynecologic Oncology 2021 Annual Clinical Meeting.
  • Alldredge J, Leaf MC, Patel P, Coakley K, Longoria T, McLaren C, Randall LM. Prevalence and predictors of HIV screening in invasive cervical cancer: a 10 year cohort study. Int J Gynecol Cancer. 2020 Jun;30(6):772-776. PubMed PMID: 32156714
  • Alldredge J, Randall L, De Robles G, Agrawal A, Mercola D, Liu M, Randhawa P, Edwards R, McClelland M, Rahmatpanah F. Transcriptome analysis of ovarian and uterine clear cell malignancies. Frontier Oncol. Dec 2020.
  • Alldredge J, Serna-Gallegos T, Gallegos N, VanLeer JP, Chang J, Ziogas A, Goreal W, Randall L. Evaluation of clear cell subtypes of ovarian and uterine malignancies with anti-PD-L1 and anti-PD1 immunohistochemical expression and their association with stage and survival. Gynecol Oncol. 2019 Oct 22. [Epub ahead of print] PubMed PMID: 31653509
  • Kim JS, Liang MI, Prendergast EN, Alldredge J, Datta A, Hurteau JA, Kirschner CV, Rodriguez G, Vogel TJ, Brooks RA, Cass I, Cohen JG, Penner KR, Wang CE, Diaz Moore ES. Clinical outcomes in ovarian cancer patients receiving three versus more cycles of chemotherapy after neoadjuvant treatment and interval cytoreductive surgery. Int J Gynecol Cancer. 2019 Sep;29(7):1156-1163. PubMed PMID: 31352365
  • Alldredge J, Randall L. Germline and Somatic Tumor Testing in Gynecologic Cancer Care. Obstet Gynecol Clin North Am. 2019 Mar;46(1):37-53. PubMed PMID: 30683265
  • D’Amora P, Silva I, Tewari K, Bristow R, Cappuccini F, Evans S, Salzberger M, Addis-Bernard P, Palma A, Marcchioni D, Carioca A, Costa Vieira R, Penner K, Alldredge J, Longoria T, Nagourney R. Platinum resistant in advanced gynecologic malignancies: Response, disease free and overall survival are predicted by biochemical signature: A metabolic analysis.
  • Hall K, Alldredge J, Post M, Berning A. Molecular evidence for epithelial origin of mixed ovarian epithelial-germ call neoplasms. American Journal of Surgical Pathology 
  • Endogenous retrovirus RNA expression differences between race, stage and HPV status offer improved prognostication among women with cervical cancer. Int J Molc Science. Jan 2023.
View All (13 Total) View Less

Professional Memberships

  • Society of Gynecologic Oncology, Fellow/Junior Faculty
  • American College of Obstetricians and Gynecologists, Junior Faculty
  • Western Association of Gynecologic Oncologists, Member

Practice Locations

CU Medicine Gynecologic Oncology - Highlands Ranch Specialty Care Center
1500 Park Central Drive
Suite 201
Highlands Ranch, CO 80129

UCHealth Gynecologic Oncology Clinic - Anschutz Medical Campus
1665 Aurora Court
Anschutz Cancer Pavilion, 2nd floor
Aurora, CO 80045

Denver Health
777 Bannock St
Denver, CO 80204

UCHealth Surgical Care - Highlands Ranch Hospital
1500 Park Central Drive
Highlands Ranch, CO 80129

Hospital Affiliation
  • University of Colorado Hospital
  • Denver Health Medical Center
  • UCHealth Highlands Ranch Hospital

Specialty Information

  • Gynecologic Oncology, Board Certification (2017)
Clinical Interests
I am privileged to care for women with gynecologic cancers and pre-cancers, as well as complex benign processes. I perform cytoreductive surgery for advanced cancers, as well as chemotherapy for women with ovarian, uterine, cervical, and vulvovaginal malignancies. I have a special interest in minimally invasive surgery, including robotic-assisted surgery with the DaVinci platform.

Care Philosophy
I become part of a patient's journey during one of the scariest times in her life. I believe that clear and honest education and good listening are the foundation of this journey. Every woman's goals are unique to her and I strive to collaborate with my patients and their families as a team as we navigate through the decisions about complicated surgeries and treatments.

Personal Interests
My family and I are avid outdoors enthusiasts - we enjoy mountain biking, camping and hiking, as well as snowboarding and sledding!

Volunteer Activities
At Colorado College, I was very active in Habitat for Humanity in the Colorado Springs area. Throughout medical school, residency, and fellowship, I have focused on mentoring other learners and quality improvement initiatives within the hospital.

Public Speaking
I enjoy teaching irregardless of my target audience - I enjoy speaking to patients, medical students or residents, physicians or communities to increase knowledge about prevention, recognition and management of disease process.

General Information

Medical Schools:
  • MD, University of New Mexico School of Medicine (2011)
Undergraduate Schools:
  • BA, Colorado College (CO) (2006)
Residency Programs:
  • University of New Mexico Program, Chief Resident, Obstetrics and Gynecology (2015)
  • University of California (Irvine) Program, Gynecologic Oncology (2019)
Download CV
Languages: English
Department: OB-GYN-Gynecologic Oncology
Contact Us
CU Anschutz
Fitzsimons Building

13001 East 17th Place
Campus Box C290
Aurora, CO 80045

Update My Profile